Ricardo Jose Moylan Governo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ricardo Jose Moylan Governo has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Victoria Chapman
University of Nottingham
5 shared publications Charles Alexander Marsden
School of Biomedical Sciences, University of Nottingham, Nottingham NG7 2UH, UK
3 shared publicationsMalcolm John William Prior
Brain and Body Centre, University of Nottingham, Nottingham NG7 2UH, UK
3 shared publicationsPeter Gordon Morris
Sir Peter Mansfield Magnetic Resonance Centre, University of Nottingham, Nottingham NG7 2UH, UK
3 shared publicationsBen Eden-Green
Department of Anaesthesia, Queen Victoria Hospital NHS Foundation Trust, East Grinstead, RH19 3DZ, UK
2 shared publicationsCharles Nduka
Department of Plastic Surgery & Burns, Queen Victoria Hospital NHS Foundation Trust, East Grinstead, RH19 3DZ, UK
2 shared publications
Latest Publications
- 1 July 2020
- Published by Taylor & Francis in Pain Management
- Vol. 10 (6) , 399-410
Evaluation of facial electromyographic pain responses in healthy participants
Aim:Assessing pain perception through self-reports may not be possible in some patients, for example, sedated. Our group considered if facial electromyography (fEMG) could provide a useful alternative, by testing on healthy participants subjected to experimental pain.Materials & methods:Activity of four facial muscles was recorded using fEMG alongside self-reported pain scores and physiological parameters.Results:The pain stimulus elicited significant activity on all facial muscles of interest as well as increases in heart rate. Activity from two of the facial muscles correlated significantly against pain intensity.Conclusion:Pain perception can be assessed through fEMG on healthy participants. We believe that this model would be valuable to clinicians that need to diagnose pain perception in circumstances where verbal reporting is not possible.
- 1 July 2020
- Published by Taylor & Francis in Pain Management
- Vol. 10 (6) , 399-410
Evaluation of facial electromyographic pain responses in healthy participants
Aim:Assessing pain perception through self-reports may not be possible in some patients, for example, sedated. Our group considered if facial electromyography (fEMG) could provide a useful alternative, by testing on healthy participants subjected to experimental pain.Materials & methods:Activity of four facial muscles was recorded using fEMG alongside self-reported pain scores and physiological parameters.Results:The pain stimulus elicited significant activity on all facial muscles of interest as well as increases in heart rate. Activity from two of the facial muscles correlated significantly against pain intensity.Conclusion:Pain perception can be assessed through fEMG on healthy participants. We believe that this model would be valuable to clinicians that need to diagnose pain perception in circumstances where verbal reporting is not possible.
- Open Access
- 26 September 2019
- Published by Medip Academy in International Journal Of Community Medicine And Public Health
- Vol. 6 (10) , 4154-4161
Healthcare workers in Saudi Arabia perceive stress differently according to gender but not in cortisol levels: an immunoassay study
Background: Working in the healthcare sector is generally regarded as stress inductive, which hampers performance, yet one demanding constant accuracy. This dichotomy has led to numerous investigations on the impact from perceived stress on hospital workers but focused primarily on employing psychological methods to determine perceived stress. This study sought to employ an arguably more objective measure of chronic stress on female healthcare professionals in Saudi Arabia, by assaying the concentration of hair cortisol (HCC) in parallel with stress questionnaires.Methods: Pharmacists, nurses and lab workers participated in providing hair samples. Cortisol levels were subsequently quantified using immunoassay methods. Investigations considered the variables of age, gender, and smoking, hair coloring or bleaching or working in shifts on both stress perception and HCC.Results: On average chronic stress was perceived comparably between the different healthcare professions and not differ significantly against the female control group. However, chronic stress differed significantly between genders within the healthcare profession. In contrast, HCC levels showed no direct relation to stress perception with respect to either gender or profession. HCC did, however, show steady decreases with respect to age, as an indirect measure of experience, that contrasted against the identical scores for stress perception. Finally, night shifts, smoking or hair colouring did not produce a significant change on HCC in the healthcare cohorts.Conclusions: Women in the healthcare profession perceive stress higher irrespective of profession compared to men. Also show a pattern of decreasing levels of cortisol with increasing age despite reporting similar stress perception against younger participants.
- 26 September 2019
- Published by Medip Academy in International Journal Of Community Medicine And Public Health
- Vol. 6 (10) , 4154-4161
Open AccessHealthcare workers in Saudi Arabia perceive stress differently according to gender but not in cortisol levels: an immunoassay study
Background: Working in the healthcare sector is generally regarded as stress inductive, which hampers performance, yet one demanding constant accuracy. This dichotomy has led to numerous investigations on the impact from perceived stress on hospital workers but focused primarily on employing psychological methods to determine perceived stress. This study sought to employ an arguably more objective measure of chronic stress on female healthcare professionals in Saudi Arabia, by assaying the concentration of hair cortisol (HCC) in parallel with stress questionnaires.Methods: Pharmacists, nurses and lab workers participated in providing hair samples. Cortisol levels were subsequently quantified using immunoassay methods. Investigations considered the variables of age, gender, and smoking, hair coloring or bleaching or working in shifts on both stress perception and HCC.Results: On average chronic stress was perceived comparably between the different healthcare professions and not differ significantly against the female control group. However, chronic stress differed significantly between genders within the healthcare profession. In contrast, HCC levels showed no direct relation to stress perception with respect to either gender or profession. HCC did, however, show steady decreases with respect to age, as an indirect measure of experience, that contrasted against the identical scores for stress perception. Finally, night shifts, smoking or hair colouring did not produce a significant change on HCC in the healthcare cohorts.Conclusions: Women in the healthcare profession perceive stress higher irrespective of profession compared to men. Also show a pattern of decreasing levels of cortisol with increasing age despite reporting similar stress perception against younger participants.
- 22 February 2018
- Published by Taylor & Francis in Pain Management
- Vol. 8 (2) , 105-113
Objectively Measuring Pain Using Facial Expression: Is the Technology Finally Ready?
Currently, clinicians observe pain-related behaviors and use patient self-report measures in order to determine pain severity. This paper reviews the evidence when facial expression is used as a measure of pain. We review the literature reporting the relevance of facial expression as a diagnostic measure, which facial movements are indicative of pain, and whether such movements can be reliably used to measure pain. We conclude that although the technology for objective pain measurement is not yet ready for use in clinical settings, the potential benefits to patients in improved pain management, combined with the advances being made in sensor technology and artificial intelligence, provide opportunities for research and innovation.
- 22 February 2018
- Published by Taylor & Francis in Pain Management
- Vol. 8 (2) , 105-113
Objectively Measuring Pain Using Facial Expression: Is the Technology Finally Ready?
Currently, clinicians observe pain-related behaviors and use patient self-report measures in order to determine pain severity. This paper reviews the evidence when facial expression is used as a measure of pain. We review the literature reporting the relevance of facial expression as a diagnostic measure, which facial movements are indicative of pain, and whether such movements can be reliably used to measure pain. We conclude that although the technology for objective pain measurement is not yet ready for use in clinical settings, the potential benefits to patients in improved pain management, combined with the advances being made in sensor technology and artificial intelligence, provide opportunities for research and innovation.
- Open Access
- 24 June 2009
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 29 (25) , 8177-8186
Opioids Depress Cortical Centers Responsible for the Volitional Control of Respiration
Respiratory depression limits provision of safe opioid analgesia and is the main cause of death in drug addicts. Although opioids are known to inhibit brainstem respiratory activity, their effects on cortical areas that mediate respiration are less well understood. Here, functional magnetic resonance imaging was used to examine how brainstem and cortical activity related to a short breath hold is modulated by the opioid remifentanil. We hypothesized that remifentanil would differentially depress brain areas that mediate sensory-affective components of respiration over those that mediate volitional motor control. Quantitative measures of cerebral blood flow were used to control for hypercapnia-induced changes in blood oxygen level-dependent (BOLD) signal. Awareness of respiration, reflected by an urge-to-breathe score, was profoundly reduced with remifentanil. Urge to breathe was associated with activity in the bilateral insula, frontal operculum, and secondary somatosensory cortex. Localized remifentanil-induced decreases in breath hold-related activity were observed in the left anterior insula and operculum. We also observed remifentanil-induced decreases in the BOLD response to breath holding in the left dorsolateral prefrontal cortex, anterior cingulate, the cerebellum, and periaqueductal gray, brain areas that mediate task performance. Activity in areas mediating motor control (putamen, motor cortex) and sensory-motor integration (supramarginal gyrus) were unaffected by remifentanil. Breath hold-related activity was observed in the medulla. These findings highlight the importance of higher cortical centers in providing contextual awareness of respiration that leads to appropriate modulation of respiratory control. Opioids have profound effects on the cortical centers that control breathing, which potentiates their actions in the brainstem.
- 24 June 2009
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 29 (25) , 8177-8186
Open AccessOpioids Depress Cortical Centers Responsible for the Volitional Control of Respiration
Respiratory depression limits provision of safe opioid analgesia and is the main cause of death in drug addicts. Although opioids are known to inhibit brainstem respiratory activity, their effects on cortical areas that mediate respiration are less well understood. Here, functional magnetic resonance imaging was used to examine how brainstem and cortical activity related to a short breath hold is modulated by the opioid remifentanil. We hypothesized that remifentanil would differentially depress brain areas that mediate sensory-affective components of respiration over those that mediate volitional motor control. Quantitative measures of cerebral blood flow were used to control for hypercapnia-induced changes in blood oxygen level-dependent (BOLD) signal. Awareness of respiration, reflected by an urge-to-breathe score, was profoundly reduced with remifentanil. Urge to breathe was associated with activity in the bilateral insula, frontal operculum, and secondary somatosensory cortex. Localized remifentanil-induced decreases in breath hold-related activity were observed in the left anterior insula and operculum. We also observed remifentanil-induced decreases in the BOLD response to breath holding in the left dorsolateral prefrontal cortex, anterior cingulate, the cerebellum, and periaqueductal gray, brain areas that mediate task performance. Activity in areas mediating motor control (putamen, motor cortex) and sensory-motor integration (supramarginal gyrus) were unaffected by remifentanil. Breath hold-related activity was observed in the medulla. These findings highlight the importance of higher cortical centers in providing contextual awareness of respiration that leads to appropriate modulation of respiratory control. Opioids have profound effects on the cortical centers that control breathing, which potentiates their actions in the brainstem.
- 1 April 2009
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 106 (4) , 1038-1049
The effect of remifentanil on respiratory variability, evaluated with dynamic modeling
Opioid drugs disrupt signaling in the brain stem respiratory network affecting respiratory rhythm. We evaluated the influence of a steady-state infusion of a model opioid, remifentanil, on respiratory variability during spontaneous respiration in a group of 11 healthy human volunteers. We used dynamic linear and nonlinear models to examine the effects of remifentanil on both directions of the ventilatory loop, i.e., on the influence of natural variations in end-tidal carbon dioxide (PetCO2) on ventilatory variability, which was assessed by tidal volume (Vt) and breath-to-breath ventilation (i.e., the ratio of tidal volume over total breath time Vt/Ttot), and vice versa. Breath-by-breath recordings of expired CO2and respiration were made during a target-controlled infusion of remifentanil for 15 min at estimated effect site (i.e., brain tissue) concentrations of 0, 0.7, 1.1, and 1.5 ng/ml, respectively. Remifentanil caused a profound increase in the duration of expiration. The obtained models revealed a decrease in the strength of the dynamic effect of PetCO2variability on Vt (the “controller” part of the ventilatory loop) and a more pronounced increase in the effect of Vt variability on PetCO2(the “plant” part of the loop). Nonlinear models explained these dynamic interrelationships better than linear models. Our approach allows detailed investigation of drug effects in the resting state at the systems level using noninvasive and minimally perturbing experimental protocols, which can closely represent real-life clinical situations.
- 1 April 2009
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 106 (4) , 1038-1049
The effect of remifentanil on respiratory variability, evaluated with dynamic modeling
Opioid drugs disrupt signaling in the brain stem respiratory network affecting respiratory rhythm. We evaluated the influence of a steady-state infusion of a model opioid, remifentanil, on respiratory variability during spontaneous respiration in a group of 11 healthy human volunteers. We used dynamic linear and nonlinear models to examine the effects of remifentanil on both directions of the ventilatory loop, i.e., on the influence of natural variations in end-tidal carbon dioxide (PetCO2) on ventilatory variability, which was assessed by tidal volume (Vt) and breath-to-breath ventilation (i.e., the ratio of tidal volume over total breath time Vt/Ttot), and vice versa. Breath-by-breath recordings of expired CO2and respiration were made during a target-controlled infusion of remifentanil for 15 min at estimated effect site (i.e., brain tissue) concentrations of 0, 0.7, 1.1, and 1.5 ng/ml, respectively. Remifentanil caused a profound increase in the duration of expiration. The obtained models revealed a decrease in the strength of the dynamic effect of PetCO2variability on Vt (the “controller” part of the ventilatory loop) and a more pronounced increase in the effect of Vt variability on PetCO2(the “plant” part of the loop). Nonlinear models explained these dynamic interrelationships better than linear models. Our approach allows detailed investigation of drug effects in the resting state at the systems level using noninvasive and minimally perturbing experimental protocols, which can closely represent real-life clinical situations.
- 1 February 2009
- Published by Elsevier in Neuropharmacology
- Vol. 56 (2) , 405-413
Identification of discrete sites of action of chronic treatment with desipramine in a model of neuropathic pain
- 1 February 2009
- Published by Elsevier in Neuropharmacology
- Vol. 56 (2) , 405-413
Identification of discrete sites of action of chronic treatment with desipramine in a model of neuropathic pain
- Open Access
- 1 April 2008
- Published by Wiley in British Journal of Pharmacology
- Vol. 153 (7) , 1558-1567
Gabapentin evoked changes in functional activity in nociceptive regions in the brain of the anaesthetized rat: an fMRI study
Background and purpose: Gabapentin (GBP; 1‐(aminomethyl)cyclohexane acetic acid) is used clinically in the treatment of pain. Nevertheless, the sites and mechanisms of action of GBP are poorly defined. Herein, the effects of GBP on brain activation have been studied.Experimental approach: Changes in blood oxygen level dependent (BOLD) haemodynamic signal following intravenous infusion of GBP (equivalent to 30 mg kg−1 p.o., followed by 100 mg kg−1 p.o.), compared to saline control, were studied in isofluorane anaesthetized rats (n=8 per group). Effects of GBP on mean arterial blood pressure (MAP) were also recorded.Results: Random effect analysis revealed that the lower dose of GBP produced significant (PP−1) produced significantly greater changes in BOLD signal intensity in several brain regions including the thalamus and PAG. MAP was not significantly altered by GBP, compared to saline.Conclusions and implications: GBP had marked positive and negative effects on BOLD signal intensity in a number of brain regions in naïve rats. The activation of key areas involved in nociceptive processing indicate a supraspinal site of action of GBP and this may contribute to its well‐described analgesic effects in animal models of pain and clinical studies.British Journal of Pharmacology (2008) 153, 1558–1567; doi:10.1038/bjp.2008.27; published online 11 February 2008
- 1 April 2008
- Published by Wiley in British Journal of Pharmacology
- Vol. 153 (7) , 1558-1567
Open AccessGabapentin evoked changes in functional activity in nociceptive regions in the brain of the anaesthetized rat: an fMRI study
Background and purpose: Gabapentin (GBP; 1‐(aminomethyl)cyclohexane acetic acid) is used clinically in the treatment of pain. Nevertheless, the sites and mechanisms of action of GBP are poorly defined. Herein, the effects of GBP on brain activation have been studied.Experimental approach: Changes in blood oxygen level dependent (BOLD) haemodynamic signal following intravenous infusion of GBP (equivalent to 30 mg kg−1 p.o., followed by 100 mg kg−1 p.o.), compared to saline control, were studied in isofluorane anaesthetized rats (n=8 per group). Effects of GBP on mean arterial blood pressure (MAP) were also recorded.Results: Random effect analysis revealed that the lower dose of GBP produced significant (PP−1) produced significantly greater changes in BOLD signal intensity in several brain regions including the thalamus and PAG. MAP was not significantly altered by GBP, compared to saline.Conclusions and implications: GBP had marked positive and negative effects on BOLD signal intensity in a number of brain regions in naïve rats. The activation of key areas involved in nociceptive processing indicate a supraspinal site of action of GBP and this may contribute to its well‐described analgesic effects in animal models of pain and clinical studies.British Journal of Pharmacology (2008) 153, 1558–1567; doi:10.1038/bjp.2008.27; published online 11 February 2008
- 1 June 2007
- Published by Elsevier in Journal of Neuroscience Methods
- Vol. 163 (1) , 31-37
Validation of an automated punctate mechanical stimuli delivery system designed for fMRI studies in rodents
- 1 June 2007
- Published by Elsevier in Journal of Neuroscience Methods
- Vol. 163 (1) , 31-37
Validation of an automated punctate mechanical stimuli delivery system designed for fMRI studies in rodents
- 1 December 2006
- Published by Wolters Kluwer Health in Pain
- Vol. 126 (1) , 35-45
Capsaicin-evoked brain activation and central sensitization in anaesthetised rats: A functional magnetic resonance imaging study
Functional magnetic resonance imaging (fMRI) of blood oxygen level dependent (BOLD) haemodynamic responses was used to study the effects of the noxious substance capsaicin on whole brain activation in isofluorane anaesthetised rats. Rats (n = 8) received intradermal injection of capsaicin (30 μg/5 μl), or topical cream (0.1%) capsaicin and BOLD responses were acquired for up to 120 min. Effects of capsaicin versus placebo cream treatment on the BOLD response to a 15 g mechanical stimulus applied adjacent to the site of cream application were also studied. Both injection and cream application of capsaicin activated brain areas involved in pain processing, including the thalamus and periaqueductal grey (PAG) (p < 0.05, corrected for multiple comparisons). Capsaicin also produced increases in BOLD signal intensity in other regions that contribute to pain processing, such as the parabrachial nucleus and superior colliculus. Mechanical stimulation in capsaicin-treated rats, but not placebo-treated rats, induced a significant decrease in BOLD signal intensity in the PAG (p < 0.001). These data demonstrate that the noxious substance capsaicin produces brain activation in the midbrain regions and reveals the importance of the PAG in central sensitization.
- 1 December 2006
- Published by Wolters Kluwer Health in Pain
- Vol. 126 (1) , 35-45
Capsaicin-evoked brain activation and central sensitization in anaesthetised rats: A functional magnetic resonance imaging study
Functional magnetic resonance imaging (fMRI) of blood oxygen level dependent (BOLD) haemodynamic responses was used to study the effects of the noxious substance capsaicin on whole brain activation in isofluorane anaesthetised rats. Rats (n = 8) received intradermal injection of capsaicin (30 μg/5 μl), or topical cream (0.1%) capsaicin and BOLD responses were acquired for up to 120 min. Effects of capsaicin versus placebo cream treatment on the BOLD response to a 15 g mechanical stimulus applied adjacent to the site of cream application were also studied. Both injection and cream application of capsaicin activated brain areas involved in pain processing, including the thalamus and periaqueductal grey (PAG) (p < 0.05, corrected for multiple comparisons). Capsaicin also produced increases in BOLD signal intensity in other regions that contribute to pain processing, such as the parabrachial nucleus and superior colliculus. Mechanical stimulation in capsaicin-treated rats, but not placebo-treated rats, induced a significant decrease in BOLD signal intensity in the PAG (p < 0.001). These data demonstrate that the noxious substance capsaicin produces brain activation in the midbrain regions and reveals the importance of the PAG in central sensitization.